Startseite Medizin Identification of pathogenic ACAN variants in healthy children with normal height and advanced bone age
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Identification of pathogenic ACAN variants in healthy children with normal height and advanced bone age

  • María Isabel Hernández ORCID logo , Vivian Gallardo , Nancy Unanue , Hermine van Duyvenvoorde ORCID logo und María Verónica Mericq ORCID logo EMAIL logo
Veröffentlicht/Copyright: 28. August 2025

Received: 2025-06-22
Accepted: 2025-08-09
Published Online: 2025-08-28
Published in Print: 2025-10-27

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. A multi-stakeholder perspective on medical devices for children and adolescents with type 1 diabetes: huge unmet needs for the smallest
  4. Original Articles
  5. Concerns for mood disorders in children presenting with early menarche is not an indication for pubertal suppression
  6. Testosterone in Duchenne muscular dystrophy: effects on puberty and growth
  7. First evaluation of fibroblast growth factor 21 levels in patients diagnosed with glycogen storage diseases with liver involvement
  8. Improving cardiometabolic health in children and adolescents with obesity: a comparison between in-person and virtual supervised training
  9. Impact of high-dose vitamin D supplementation initiated shortly after diagnosis on residual beta cell function and partial remission rates in children with type 1 diabetes
  10. Clinical spectrum, imaging characteristics, and treatment outcomes of pediatric adrenocortical tumors: a 24-year experience from Western India
  11. Comparison study of the correlation between free and total 25(OH)D in maternal and umbilical blood and early-life physical development parameters
  12. Hashimoto’s thyroiditis in children and adolescents: analysis of long-term course
  13. Case Reports
  14. 45, X/46, XY mosaicism and gender incongruence: ethical, medical, and psychological considerations
  15. Hormone-active ovarian steroid cell tumor in a 2-year-old girl
  16. Lipoatrophy following weekly growth hormone therapy: a case report
  17. Surgical treatment and somatostatin experience in growth hormone-secreting pituitary macroadenoma due to novel AIP mutation
  18. Letters to the Editor
  19. ANKS1B is a potential candidate gene for short stature and failure to thrive in children
  20. Identification of pathogenic ACAN variants in healthy children with normal height and advanced bone age
Heruntergeladen am 21.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2025-0408/html
Button zum nach oben scrollen